Details
Stereochemistry | RACEMIC |
Molecular Formula | C24H26N2O4 |
Molecular Weight | 406.4742 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(OCCNCC(O)COC2=CC=CC3=C2C4=C(N3)C=CC=C4)C=CC=C1
InChI
InChIKey=OGHNVEJMJSYVRP-UHFFFAOYSA-N
InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3
Molecular Formula | C24H26N2O4 |
Molecular Weight | 406.4742 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:57:34 UTC 2023
by
admin
on
Fri Dec 15 14:57:34 UTC 2023
|
Record UNII |
0K47UL67F2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000009923
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
||
|
NDF-RT |
N0000175556
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
||
|
WHO-ATC |
C07FX06
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
||
|
LIVERTOX |
NBK548399
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
||
|
NDF-RT |
N0000175553
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
||
|
WHO-VATC |
QC07AG02
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
||
|
NDF-RT |
N0000009924
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
||
|
NCI_THESAURUS |
C29576
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
||
|
WHO-ATC |
C07AG02
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
||
|
NDF-RT |
N0000000099
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL723
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
DTXSID8022747
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
0K47UL67F2
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
1096622
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
C043211
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
C28906
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
DB01136
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
Carvedilol
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
522
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
ARTIST
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | APPROVED AUGUST 2015 | ||
|
20352
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB06153MIG
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
551
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
758694
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
m3143
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | Merck Index | ||
|
0K47UL67F2
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
7044
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
Z-25
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
Carvedilol
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
2585
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
5333
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
72956-09-3
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
3441
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY | |||
|
100000092577
Created by
admin on Fri Dec 15 14:57:34 UTC 2023 , Edited by admin on Fri Dec 15 14:57:34 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TRANSPORTER -> INHIBITOR |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
ENANTIOMER -> RACEMATE | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
TARGET -> AGONIST |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
PLASMA
|
||
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE ACTIVE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
HEART FAILURE, MORE THAN 85 kg |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||